1. Home
  2. Directory
  3. Colorado
  4. Parker
  5. Pharmacist
  6. NPI Profile
  7. Prescriptions 1366727331

ROBERT FOX
Prescription History 1366727331
Pharmacist in Parker, CO

NPI Status: Active since October 20, 2011

Contact Information

18414 COTTONWOOD DR
PARKER, CO
ZIP 80138
Phone: (303) 583-1946

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ROBERT FOX, an active Pharmacist specialist practicing in Parker, CO. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 294 documented patient claims. Among these therapy options, the most frequently utilized medication is Abrysvo, which accounts for 141 claims alone.

Medication Index

A
B
S
No matching medications currently found on file.

Abrysvo

Generic Formulation: Rsv Vacc, Pref A And Pref B/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 141
30-Day Fills 141.0
Days Supply 141
CO State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$330.05

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Adacel Tdap

Generic Formulation: Diph,pertuss(Acell),tet Vac/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 12
CO State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills23.5
Peer Average Days Supply26
Conservative Utilization

This provider writes prescriptions for this formulation 47.8% less frequently than the standard regional baseline metric for practitioners inside CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $744.75 across this reporting matrix range.

Provider Avg Cost Per Claim

$62.06

State Avg Cost Per Claim

$58.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This vaccine is used to keep up protection (immunity) against diphtheria, tetanus (lockjaw) and pertussis (whooping cough) in children and adults who have been vaccinated for these diseases in the past. It may also be given during the third trimester of pregnancy to help prevent pertussis in the newborn baby. Vaccination is the best way to protect against these life-threatening diseases. Vaccines work by causing the body to produce its own protection (antibodies). Booster doses are needed to keep up immunity because antibody levels may become too low over time to provide the needed protection.

Boostrix Tdap

Generic Formulation: Diphth,pertuss(Acell),tet VacSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 23
30-Day Fills 23.0
Days Supply 23
CO State Average Benchmarks
Peer Average Claims104.0
Peer Average 30-Day Fills104.3
Peer Average Days Supply113
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 77.9% less volume than the regional standard for practitioners inside CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,301.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$56.60

State Avg Cost Per Claim

$65.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Shingrix

Generic Formulation: Varicella-Zoster Ge/As01b/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 118
30-Day Fills 118.0
Days Supply 118
CO State Average Benchmarks
Peer Average Claims146.0
Peer Average 30-Day Fills146.6
Peer Average Days Supply172
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $24,501.67 across this reporting matrix range.

Provider Avg Cost Per Claim

$207.64

State Avg Cost Per Claim

$199.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like ROBERT FOX provides transparency into local medical care patterns within Parker, CO.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pharmacist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.